Form 4 for ASTH Astrana Health, Inc.
Accepted 2023-10-17 00:00:00 ET · period of report 2023-04-14 · accession 0001104659-23-109615 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-17 | 2023-04-14 | ASTH | Basho Chandan | See Remarks | F - Tax | $39.06 | -2,494 | 74.4K | -3% | -$97.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-14 | F | D | 2,494 | $39.06 | 74,445 | D | — | — | (F1) This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award which vested on April 14, 2023. (F2) Includes 69,726 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,640 shares, which vest in three equal annual installments on April 14, 2024, 2025, and 2026; and (ii) 48,086 shares, which vest upon achievement of certain pre-established performance goals. |